Cost is usually the second question people ask about tirzepatide. The first is whether it works. The second, almost always, is some version of “okay, what is this actually going to run me every month?”
It is a fair question and a frustrating one, because the honest answer is that tirzepatide has at least four different prices depending on how you get it, what dose you are on, whether you have coverage, and whether you refill on time. The number someone quotes you in a Facebook group may have nothing to do with what you will pay.
Here is the real breakdown as of August 2026, including the parts that changed recently and caught a lot of patients off guard.
What tirzepatide actually is, briefly
Tirzepatide is a dual GIP and GLP-1 receptor agonist given as a once-weekly injection. It goes by two brand names, and they are the same molecule approved for different things. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management in adults with obesity, or in adults who are overweight and have at least one weight-related condition.
That distinction matters for cost more than most people expect, because it drives what your insurance will and will not pay for. If you want the fuller comparison against semaglutide, we covered that in our guide to choosing between the two.
Brand-name tirzepatide: what you pay without insurance
Eli Lilly sells Zepbound directly to self-pay patients, and those published prices are the cleanest benchmark available. As of this writing, the self-pay price for a one-month supply of the single-patient-use pen runs $299 at 2.5 mg, $399 at 5 mg, and $449 for every dose from 7.5 mg up through 15 mg.
Two conditions are attached to that, and they trip people up:
- The 45-day refill window. To keep the $449 price at the higher doses, you have to complete your next refill within 45 days of the previous one. Miss it and you fall back to standard pricing, which is $499 at 7.5 mg and $699 at 10 mg and above.
- An annual fill cap. The program allows up to 11 prescription fills per calendar year.
Those prices came down meaningfully in early 2026. If you researched tirzepatide a year or two ago and walked away because the number was over a thousand dollars a month, that figure is out of date. Check it again before you rule anything out. Lilly adjusts this pricing periodically, so treat any number you read online, including this one, as a starting point to verify rather than a quote.
What insurance actually covers
This is where it gets uneven. Coverage for tirzepatide splits along the diabetes and obesity line almost every time.
If you have type 2 diabetes and your plan covers Mounjaro, your out-of-pocket cost can drop to a standard specialty copay, sometimes a lot less than the self-pay prices above. If you are taking it for weight management, coverage is far less predictable. Plenty of commercial plans exclude anti-obesity medications outright as a category, regardless of your BMI or your comorbidities. Medicare has historically not covered medications prescribed solely for weight loss.
A few things worth doing before you assume you are not covered:
- Call the member services number on your card and ask specifically whether anti-obesity medications are a covered benefit on your plan, separate from asking about the drug by name.
- Ask whether prior authorization is required and what documentation it needs. Many plans that do cover it want documented BMI, a weight-related condition, and sometimes a trial of lifestyle intervention first.
- If you have a commercial plan that covers it, look at Lilly’s savings card, which can bring the pen down substantially for eligible patients.
- Check whether your HSA or FSA can absorb the cost. For most patients with a qualifying prescription, it can.
Why your cost changes as your dose goes up
Tirzepatide is not a fixed monthly expense. You titrate up, and the price tiers move with you.
The standard approach starts at 2.5 mg once weekly for four weeks. That first month is a tolerance-building dose, not a treatment dose. From there you step up to 5 mg, and after that your provider can increase in 2.5 mg increments, holding at least four weeks at each step. Maintenance typically lands at 5, 10, or 15 mg depending on how you respond and what you tolerate.
The practical budgeting implication: your cheapest month is your first one, and your cost climbs over the first few months before flattening out. Patients who budget off the starting price get an unwelcome surprise in month three. Plan around your likely maintenance dose instead, not your starting dose.
It also means that stopping and restarting is expensive in a way people underestimate. Come off for several months and you generally have to retitrate from a low dose, paying for ramp-up months all over again.
Where compounded tirzepatide fits now
For a stretch in 2023 and 2024, compounded tirzepatide was widely available and much cheaper, because the drug was on the FDA’s shortage list and compounding rules loosened accordingly. That window has closed, and a lot of the pricing people still quote comes from it.
The FDA declared the tirzepatide shortage resolved in October 2024. The enforcement discretion that followed ended in early 2025, and tirzepatide no longer appears on the FDA’s drug shortage list or on the 503B bulks list that outsourcing facilities compound from.
What that leaves is a narrower, patient-specific pathway. Under section 503A, a compounded drug is made for an individual patient based on a prescription, and a compounder is not permitted to regularly make products that are essentially copies of a commercially available drug. The exception the FDA describes is when a prescriber determines and documents that the compounded product contains a change producing a significant difference for that specific patient.
Read that carefully, because it is the whole point. That determination is a clinical judgment a prescriber has to make and document for you individually. It is not something a web form can decide, and it is not a volume business. If a website offers you compounded tirzepatide after a five-question intake and no examination, that is worth a hard look. The FDA has been sending warning letters to sellers in this space, and products sourced outside a licensed US pharmacy carry real risks around purity, concentration, and dosing accuracy.
Cheaper is not automatically the better deal when what you are injecting weekly may not contain what the label claims.
The costs nobody puts in the estimate
The medication is the biggest line item, not the only one. A complete budget also includes:
- Baseline labs. A1c, thyroid, kidney and liver function, and a lipid panel are reasonable before starting, and worth repeating periodically.
- Follow-up visits. Dose adjustments should be made by someone who is actually looking at your response, your side effects, and your body composition, not just refilling on autopilot.
- Protein and strength training. Not a fee, but a real change in how you eat and train. Losing weight quickly on a GLP-1 without protecting muscle is a common and avoidable mistake. We wrote about that in detail in how to prevent muscle loss on GLP-1 medications.
When you compare two programs, compare what is bundled. A lower medication price with labs, visits, and follow-up billed separately is not necessarily cheaper than a program that includes them.
How we handle cost at Olympia Aesthetics & Wellness
Our medical weight loss program is provider-led and priced at consultation, because the honest answer depends on your labs, your starting point, and the dose you end up on. We would rather quote you a real number after an evaluation than advertise a teaser price that changes the moment you titrate up.
What is consistent: you are evaluated in person, Dr. Oliver Morris reviews your history and your labs, dosing is individualized rather than pushed on a fixed schedule, and you are seen monthly while you titrate. If you want the local specifics on dosing timelines and what the first few months look like, our Palm Harbor tirzepatide guide goes deeper, and the complete medical weight loss guide covers the full program.
The bottom line
Budget somewhere in the $300 to $450 per month range for brand-name tirzepatide if you are paying cash, less if your plan covers it, and expect that number to rise as you titrate toward a maintenance dose. Verify current pricing directly rather than trusting a figure from a forum post. Add labs and visits to whatever number you land on. And be skeptical of anything priced far below the market without a licensed pharmacy and a real prescriber behind it.
Ready to find out what this would actually cost for you? Call us at (727) 274-1972 or book online at olympiaaesthetics.com/contact/.
This article is general information, not medical advice. Medication pricing changes frequently and coverage varies by plan. Talk with a qualified provider about whether tirzepatide is appropriate for you.
